2025-07-08 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc (TDOC) based on the data you provided, presented in English with a focus on key numbers and concise analysis.

**Report on Teladoc Health Inc (TDOC)**

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** TDOC
*   **Company Overview:** Teladoc Health Inc is a telehealth company offering virtual healthcare services.
*   **TDOC Cumulative Return:** -63.10%
*   **VOO (S&P 500) Cumulative Return:** 97.22%
*   **Absolute Divergence:** -159.5
*   **Relative Divergence:** 0.0

**Analysis:** TDOC has significantly underperformed the S&P 500, with a large negative divergence in cumulative returns. The Relative Divergence indicates that the current underperformance is near the lowest end of its historical range relative to the S&P 500.

**Alpha/Beta Analysis Table:**

| Year       | CAGR     | MDD    | Alpha    | Beta   | Cap(B) |
|------------|----------|--------|----------|--------|--------|
| 2015-2017  | 76.0%    | 60.6%  | 50.0%    | -0.0   | 6.0    |
| 2016-2018  | 128.0%   | 59.3%  | 110.0%   | -0.0   | 8.5    |
| 2017-2019  | 176.0%   | 59.3%  | 147.0%   | 0.4    | 14.3   |
| 2018-2020  | 237.0%   | 64.0%  | 217.0%   | 0.1    | 34.1   |
| 2019-2021  | -83.0%   | 64.0%  | -132.0%  | 0.1    | 15.7   |
| 2020-2022  | -295.0%  | 81.3%  | -297.0%  | 0.0    | 4.0    |
| 2021-2023  | -488.0%  | 81.3%  | -506.0%  | -0.6   | 3.7    |
| 2022-2024  | -111.0%  | 81.3%  | -137.0%  | -0.8   | 1.6    |
| 2023-2025  | -34.0%   | 72.9%  | -82.0%   | -0.8   | 1.4    |

**Analysis:**  The table shows a dramatic decline in performance in recent years.  CAGR has turned negative, Maximum Drawdown (MDD) remains high, and Alpha is significantly negative, indicating underperformance relative to its benchmark. Beta has fluctuated and generally remained low. Cap (B) refers to market capitalization, and it has decreased significantly in recent years.

**2. Recent Stock Price Movement**

*   **Current Price:** 8.29
*   **Last Market Data:** price: 8.03, previousClose: 8.29, change: -3.14
*   **5-Day Moving Average:** 8.46
*   **20-Day Moving Average:** 7.61
*   **60-Day Moving Average:** 7.28

**Analysis:** The current price is below the 5-day moving average but above the 20-day and 60-day moving averages. The recent price decrease (-3.14) shows the stock had a negative day.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 64.74
*   **PPO:** 1.46
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (4 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Divergence Change:** -0.1 (Short-term decline)
*   **Expected Return:** -9486.6%

**Analysis:** The MRI indicates a low-risk market environment. The RSI is approaching overbought levels.  The PPO is positive, suggesting short-term upward momentum. The Hybrid Signal suggests a cautious buy signal. The negative change in the relative divergence indicates a short-term decline relative to the S&P 500. The expected return is highly negative, suggesting significant underperformance compared to the S&P 500 over the long term if current trends continue. The "Last Market Data" with a change of -3.14 % indicates a recent drop in the stock price.

**4. Recent News & Significant Events**

*   **2025-07-05:** Major business developments, regulatory changes, or market events.
*   **2025-07-04:** Analyst discussions on recent performance and industry trends.
*   **2025-07-06:** Notable stock volatility.
*   **2025-07-08:** Market expert advice to monitor news and announcements.

**Analysis:**  The news snippets point to recent events causing volatility and requiring investor attention.  Analyst discussions suggest a focus on the company's performance in the context of broader industry factors.

**5. Recent Earnings Analysis:**

| Date       | EPS   | Revenue     |
|------------|-------|-------------|
| 2025-05-01 | -0.53 | $0.63B      |
| 2024-10-31 | -0.19 | $0.64B      |
| 2024-08-01 | -4.92 | $0.64B      |
| 2024-04-26 | -0.49 | $0.65B      |
| 2025-05-01 | -0.49 | $0.65B      |

**Analysis:** The company has consistently reported negative EPS, although some quarters show improvement. Revenue has been relatively stable around $0.63B-$0.65B.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.63B  | 68.73%        |
| 2024-12-31 | $0.64B  | 70.50%        |
| 2024-09-30 | $0.64B  | 71.94%        |
| 2024-06-30 | $0.64B  | 70.73%        |
| 2024-03-31 | $0.65B  | 69.89%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE      |
|------------|---------|----------|
| 2025-03-31 | $1.43B  | -6.52%   |
| 2024-12-31 | $1.49B  | -3.25%   |
| 2024-09-30 | $1.51B  | -2.21%   |
| 2024-06-30 | $1.50B  | -55.77%  |
| 2024-03-31 | $2.29B  | -3.58%   |

**Analysis:** Revenue has been relatively stable. Profit margins are high, indicating operational efficiency. However, the company has negative ROE, reflecting losses relative to equity. The significant drop in equity from Q1 2024 to subsequent quarters is noteworthy.

**7. Overall Analysis**

TDOC has significantly underperformed the S&P 500, with a large negative divergence in cumulative returns. A recent drop in stock price, high profit margins, and notable stock volatility. Earnings have been consistently negative, despite stable revenue. While the profit margins are relatively high, negative ROE indicates that the company is losing money relative to its equity. Recent news suggests the company is undergoing significant developments, and market experts advise monitoring news and company announcements. The hybrid signal suggests a cautious buy signal.

